Coffee and Health

Teas, Cocoa and Coffee: Plant Secondary Metabolites and Health

Volumn , Issue , 2011, Pages 169-192

  Williamson, Gary ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Caffeine, alkaloid in coffee; Chemical tests' antioxidant; Coffea arabica L., Coffea canephora; Coffee and health; Coffee and inflammation; Coffee consumption; Coffee, cardiovascular effect; Diabetes mellitus; Elevated blood glucose; Plasma antioxidant

Indexed keywords

EID: 84888673709     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444347098.ch6     Document Type: Chapter

References (84)

1. Aldughpassi, A. and Wolever, T.M. (2009) Effect of coffee and tea on the glycaemic index of foods: no effect on mean but reduced variability. Br. J. Nutr., 101, 1282-1285.
2. Altmaier, E., Kastenmuller, G., Romisch-Margl, W. et al. (2009) Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol. Nutr. Food Res., 53, 1357-1365.
3. Arab, L. (2010) Epidemiologic evidence on coffee and cancer. Nutr. Cancer, 62, 271-283.
4. Balk, L., Hoekstra, T. and Twisk, J. (2009) Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur. J. Epidemiol, 24, 203-209.
5. Bandera, E.V., Williams-King, M.G., Sima, C. et al. (2010) Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes Control, 21, 1467-1473.
6. Battram, D.S., Arthur, R., Weekes, A. et al. (2006) The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J. Nutr., 136, 1276-1280.
7. Benvenga, S., Bartolone, L., Pappalardo, M.A. et al. (2008) Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid, 18, 293-301.
8. Bichler, J., Cavin, C., Simic, T. et al. (2007) Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4, 3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers. Food Chem. Toxicol., 45, 1428-1436.
9. Bidel, S., Silventoinen, K., Hu, G. et al. (2008) Coffee consumption, serum γ -glutamyltransferase and risk of type II diabetes. Eur. J. Clin. Nutr., 62, 178-185.
10. Borrelli, R.C., Visconti, A., Mennella, C. et al. (2002) Chemical characterization and antioxidant properties of coffee melanoidins. J. Agric. Food Chem, 50, 6527-6533.
11. Bravi, F., Scotti, L., Bosetti, C. et al. (2009) Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am. J. Obstet. Gynecol, 200, 130-135.
12. Buscemi, S., Verga, S., Batsis, J.A. et al. (2009) Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur. J. Clin. Nutr., 63, 1200-1205.
13. Buscemi, S., Verga, S., Batsis, J.A. et al. (2010) Acute effects of coffee on endothelial function in healthy subjects. Eur. J. Clin. Nutr., 64, 483-489.
14. Ceriello, A. and Motz, E. (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol., 24, 816-823.
15. Clifford, M.N. (1998) The nature of chlorogenic acids - are they advantageous compounds in coffee? In Proceedings of the 17th International Conference on Coffee Science, Nairobi, ASIC, Paris, pp. 79-91.
16. Clifford, M.N. (2000) Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J. Sci. Food Agric., 80, 1033-1043.
17. Cornelis, M.C. and El-Sohemy, A. (2007) Coffee, caffeine, and coronary heart disease. Curr. Opin. Lipidol., 18, 13-19.
18. Dias, R.C., Campanha, F.G., Vieira, L.G. et al. (2010) Evaluation of kahweol and cafestol in coffee tissues and roasted coffee by a new high-performance liquid chromatography methodology. J. Agric. Food Chem., 58, 88-93.
19. Driessen, M.T., Koppes, L.L., Veldhuis, L. et al. (2009) Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur. J. Clin. Nutr., 63, 536-542.
20. Esposito, F., Morisco, F., Verde, V. et al. (2003) Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment. Pharmacol. Ther., 17, 595-601.
21. Fuhrman, B.J., Smit, E., Crespo, C.J. et al. (2009) Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program. Public Health Nutr., 12, 842-848.
22. Geleijnse, J.M. (2008) Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc. Health Risk Manag., 4, 963-970.
23. George, S.E., Ramalakshmi, K. and Mohan Rao, L.J. (2008) A perception on health benefits of coffee. Crit. Rev. Food Sci. Nutr., 48, 464-486.
24. Greenberg, J.A., Owen, D.R. and Geliebter, A. (2010) Decaffeinated coffee and glucose metabolism in young men. Diabetes Care, 33, 278-280.
25. Grabben, M.J., Boers, G.H., Blom, H.J. et al. (2000) Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am. J. Clin. Nutr., 71, 480-484.
26. Hamer, M., Witte, D.R., Mosdol, A. et al. (2008) Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. Br. J. Nutr., 100, 1046-1053.
27. Heckman, M.A., Weil, J. and Gonzalez de Mejia, E. (2010) Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J. Food Sci., 75, R77-R87.
28. Higdon, J.V. and Frei, B. (2006) Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr., 46, 101-123.
29. Huang, D., Ou, B. and Prior, R.L. (2005) The chemistry behind antioxidant capacity assays. J. Agric. Food Chem, 53, 1841-1856.
30. Hurrell, R.F., Reddy, M. and Cook, J.D. (1999) Inhibition of non-haem iron absorption in man by polyphenolic- containing beverages. Br. J. Nutr., 81, 289-295.
31. Huxley, R., Lee, C.M., Barzi, F. et al. (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch. Intern. Med., 169, 2053-2063.
32. Je, Y., Liu, W. and Giovannucci, E. (2009) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int. J. Cancer, 124, 1662-1668.
33. Johnston, K.L., Clifford, M.N. and Morgan, L.M. (2003) Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr., 78, 728-733.
34. Kempf, K., Herder, C., Erlund, I. et al. (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am. J. Clin. Nutr., 91, 950-957.
35. Kitts, D.D. and Wijewickreme, A.N. (1994) Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems. Plant Foods Hum. Nutr., 45, 287-298.
36. Kleemola, P., Jousilahti, P., Pietinen, P. et al. (2000) Coffee consumption and the risk of coronary heart disease and death. Arch. Intern. Med., 160, 3393-3400.
37. Lafay, S., Gil-Izquierdo, A., Manach, C. et al. (2006) Chlorogenic acid is absorbed in its intact form in the stomach of rats. J. Nutr, 136, 1192-1197.
38. Larsson, S.C., Mannisto, S., Virtanen, M.J. et al. (2008) Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke, 39, 1681-1687.
39. Legrand, D. and Scheen, A.J. (2007) Does coffee protect against type 2 diabetes?. Rev. Med. Liege, 62, 554-559.
40. Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K.M. et al. (2009) Coffee consumption and risk of stroke in women. Circulation, 119, 1116-1123.
41. Louie, J.C., Atkinson, F., Petocz, P. et al. (2008) Delayed effects of coffee, tea and sucrose on postprandial glycemia in lean, young, healthy adults. Asia Pac. J. Clin. Nutr., 17, 657662.
42. Maki, T., Pham, N.M., Yoshida, D. et al. (2010) The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin. Chem. Lab Med., 48, 849-854.
43. Matsunaga, K., Katayama, M., Sakata, K. et al. (2002) Inhibitory effects of chlorogenic acid on azoxymethane-induced colon carcinogenesis in male F344 rats. Asian Pac. J. Cancer Prev, 3, 163-166.
44. Moisey, L.L., Kacker, S., Bickerton, A.C. et al. (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am. J. Clin. Nutr., 87, 1254-1261.
45. Moisey, L.L., Robinson, L.E. and Graham, T.E. (2010) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br. J. Nutr., 103, 833-841.
46. Moura-Nunes, N., Perrone, D., Farah, A. et al. (2009) The increase in human plasma antioxidant capacity after acute coffee intake is not associated with endogenous non-enzymatic antioxidant components. Int. J. Food Sci. Nutr., in press.
47. Mursu, J., Voutilainen, S., Nurmi, T. et al. (2005) The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radic. Biol. Med., 38, 527-534.
48. Natella, F., Nardini, M., Giannetti, I. et al. (2002) Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem, 50, 6211-6216.
49. Natella, F., Nardini, M., Belelli, F. et al. (2007) Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am. J. Clin. Nutr, 86, 604-609.
50. Natella, F., Nardini, M., Belelli, F. et al. (2008) Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br. J. Nutr., 100, 1276-1282.
51. Nilsson, L.M., Johansson, I., Lenner, P. et al. (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control, 21, 1533-1544.
52. Noordzij, M., Uiterwaal, C.S., Arends, L.R. et al. (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J. Hypertens, 23, 921-928.
53. Ochiai, R., Jokura, H., Suzuki, A. et al. (2004) Green coffee bean extract improves human vasoreactivity. Hypertens. Res., 27, 731-737.
54. Odegaard, A.O., Pereira, M.A., Koh, W.P. et al. (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am. J. Clin. Nutr., 88, 979-985.
55. Olthof, M.R., Hollman, P.C., Zock, P.L. et al. (2001) Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am. J. Clin. Nutr., 73, 532-538.
56. Peterson, S., Yuan, JM., Koh, W.P. et al. (2010) Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutr. Cancer, 62, 21-29.
57. Pimentel, G.D., Zemdegs, J.C., Theodoro, J.A. et al. (2009) Does long-term coffee intake reduce type 2 diabetes mellitus risk? Diabetol. Metab Syndr., 1, 6.
58. Ranheim, T. and Halvorsen, B. (2005) Coffee consumption and human health-beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol. Nutr. Food Res., 49, 274284.
59. Sartorelli, D.S., Fagherazzi, G., Balkau, B. et al. (2010) Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am. J. Clin. Nutr., 91, 1002-1012.
60. Shimizu, M., Yoshimi, N., Yamada, Y. et al. (1999) Suppressive effects of chlorogenic acid on N-methyl-N-nitrosourea-induced glandular stomach carcinogenesis in male F344 rats. J. Toxicol. Sci., 24, 433-439.
61. Sies, H. (2007) Total antioxidant capacity: appraisal of a concept. J. Nutr., 137, 1493-1495.
62. Sofi, F., Conti, A.A., Gori, A.M. et al. (2007) Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr. Metab. Cardiovasc. Dis., 17, 209-223.
63. Somoza, V., Lindenmeier, M., Wenzel, E. et al. (2003) Activity-guided identification of a chemo-preventive compound in coffee beverage using in vitro and in vivo techniques. J. Agric. Food Chem., 51, 6861-6869.
64. Steinkellner, H., Hoelzl, C., Uhl, M. et al. (2005) Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/-)-anti-benzo[a]pyrene-7, 8-dihydrodiol-9, 10-epoxide induced DNA-damage: results of controlled human intervention trials. Mutat. Res., 591, 264-275.
65. Tanaka, K., Tokunaga, S., Kono, S. et al. (1998) Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int. J. Epidemiol., 27, 438-443.
66. Tang, N., Zhou, B., Wang, B. et al. (2009) Coffee consumption and risk of breast cancer: a metaanalysis. Am. J. Obstet. Gynecol., 200, 290-299.
67. Tang, N., Wu, Y., Ma, J. et al. (2010) Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer, 67, 17-22.
68. Thom, E. (2007) The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J. Int. Med. Res., 35, 900-908.
69. Tunnicliffe, J.M. and Shearer, J. (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl. Physiol. Nutr. Metab, 33, 1290-1300.
70. Ulvik, A., Vollset, S.E., Hoff, G. et al. (2008) Coffee consumption and circulating B-vitamins in healthy middle-aged men and women. Clin. Chem, 54, 1489-1496.
71. van Dam, R.M. (2006a) Coffee and type 2 diabetes: from beans to beta-cells. Nutr. Metab Cardiovasc. Dis., 16, 69-77.
72. van Dam, R.M. (2006b) Green tea, coffee, and diabetes. Ann. Intern. Med., 145, 634-635.
73. van Dam RM (2008a) Coffee consumption and coronary heart disease: paradoxical effects on biological risk factors versus disease incidence. Clin. Chem, 54, 1418-1420.
74. van Dam, R.M. (2008b) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl. Physiol. Nutr. Metab., 33, 1269-1283.
75. van Dam, R.M. and Hu, F.B. (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA, 294, 97-104.
76. van Dam, R.M., Willett, W.C., Manson, J.E. et al. (2006c) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care, 29, 398-403.
77. van Dieren, S., Uiterwaal, C.S., van der Schouw, Y.T. et al. (2009) Coffee and tea consumption and risk of type 2 diabetes. Diabetologia, 52, 2561-2569.
78. van Dijk, A.E., Olthof, M.R., Meeuse, J.C. et al. (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care, 32, 1023-1025.
79. Watanabe, T., Arai, Y., Mitsui, Y. et al. (2006) The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin. Exp. Hypertens., 28, 439-449.
80. Williams, C.J., Fargnoli, J.L., Hwang, J.J. et al. (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care, 31, 504-507.
81. Wu, J.N., Ho, S.C., Zhou, C. et al. (2009) Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int. J. Cardiol, 137, 216-225.
82. Yamaguchi, T., Chikama, A., Mori, K. et al. (2008) Hydroxyhydroquinone-free coffee: a doubleblind, randomized controlled dose-response study of blood pressure. Nutr. Metab. Cardiovasc. Dis., 18, 408-414.
83. Yukawa, G.S., Mune, M., Otani, H. et al. (2004) Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry (Mosc.), 69, 70-74.
84. Zhang, Y., Lee, E.T., Cowan, L.D. et al. (2011) Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study. Nutr. Metab. Cardiovasc. Dis., 21, 418-423.